APA (7th ed.) Citation

PR, C., A, G. L., CS, R., M, M., JE, C., OG, C., . . . D, G. (2021). Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible. Transplantation and cellular therapy, 27(3), 259.e1-259.e6. https://doi.org/10.1016/j.jtct.2020.12.006

Chicago Style (17th ed.) Citation

PR, Colunga-Pedraza, Gómez-De León A, Rodríguez-Roque CS, Morcos-Sandino M, Colunga-Pedraza JE, Cantú-Rodriguez OG, Gutiérrez-Aguirre CH, and Gómez-Almaguer D. "Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible." Transplantation and Cellular Therapy 27, no. 3 (2021): 259.e1-259.e6. https://doi.org/10.1016/j.jtct.2020.12.006.

MLA (9th ed.) Citation

PR, Colunga-Pedraza, et al. "Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible." Transplantation and Cellular Therapy, vol. 27, no. 3, 2021, pp. 259.e1-259.e6, https://doi.org/10.1016/j.jtct.2020.12.006.